Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 402

1.

Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.

Hermans SM, van Leth F, Manabe YC, Hoepelman AI, Lange JM, Kambugu A.

HIV Med. 2012 Jul;13(6):337-44. doi: 10.1111/j.1468-1293.2011.00980.x. Epub 2012 Feb 2.

2.

Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.

Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, Rutherford G, Mermin J.

AIDS. 2007 Mar 30;21(6):713-9.

PMID:
17413692
3.

Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.

Kassa A, Teka A, Shewaamare A, Jerene D.

Trans R Soc Trop Med Hyg. 2012 Jun;106(6):363-70. doi: 10.1016/j.trstmh.2012.03.002. Epub 2012 Apr 20.

PMID:
22521216
4.

Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.

Worodria W, Massinga-Loembe M, Mazakpwe D, Luzinda K, Menten J, Van Leth F, Mayanja-Kizza H, Kestens L, Mugerwa RD, Reiss P, Colebunders R; TB-IRIS Study Group.

J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):32-7. doi: 10.1097/QAI.0b013e3182255dc2.

PMID:
21654499
5.

Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.

Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, Silva G, Santos J, Wells C, Paine P, Garrett D.

PLoS One. 2007 Sep 5;2(9):e826.

6.

Two-year treatment outcomes of patients enrolled in India's national first-line antiretroviral therapy programme.

Bachani D, Garg R, Rewari BB, Hegg L, Rajasekaran S, Deshpande A, Emmanuel KV, Chan P, Rao KS.

Natl Med J India. 2010 Jan-Feb;23(1):7-12.

PMID:
20839585
7.

Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.

Hermans SM, Manabe YC, Kiragga AN, Hoepelman AI, Lange JM, van Leth F.

Antivir Ther. 2013;18(4):615-22. doi: 10.3851/IMP2525. Epub 2013 Feb 19.

PMID:
23423604
8.

Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART.

Worodria W, Massinga-Loembe M, Mayanja-Kizza H, Namaganda J, Kambugu A, Manabe YC, Kestens L, Colebunders R.

Clin Dev Immunol. 2011;2011:758350. doi: 10.1155/2011/758350. Epub 2010 Dec 8.

9.

The prognostic value of baseline CD4(+) cell count beyond 6 months of antiretroviral therapy in HIV-positive patients in a resource-limited setting.

Mills EJ, Bakanda C, Birungi J, Yaya S, Ford N; TASO-CAN Writing Group.

AIDS. 2012 Jul 17;26(11):1425-9. doi: 10.1097/QAD.0b013e328354bf43.

PMID:
22526520
10.

Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, Manabe YC.

PLoS One. 2010 May 7;5(5):e10527. doi: 10.1371/journal.pone.0010527.

11.

Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand.

Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Vibhagool A.

J Infect. 2006 Mar;52(3):188-94. Epub 2005 Jun 29.

PMID:
15992932
12.

Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.

Dembélé M, Saleri N, Carvalho AC, Saouadogo T, Hien AD, Zabsonre I, Koala ST, Simporé J, Matteelli A.

Int J Tuberc Lung Dis. 2010 Mar;14(3):318-23.

PMID:
20132623
14.

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.

Moh R, Danel C, Messou E, Ouassa T, Gabillard D, Anzian A, Abo Y, Salamon R, Bissagnene E, Seyler C, Eholié S, Anglaret X.

AIDS. 2007 Nov 30;21(18):2483-91.

PMID:
18025885
15.

Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy.

Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):42-6.

PMID:
16885778
16.

Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.

Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S.

J Infect. 2006 Dec;53(6):357-63. Epub 2006 Feb 17.

PMID:
16487593
17.

Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery.

Hermans SM, van Leth F, Kiragga AN, Hoepelman AI, Lange JM, Manabe YC.

Trop Med Int Health. 2012 Dec;17(12):1527-33. doi: 10.1111/tmi.12001. Epub 2012 Nov 6.

18.
19.

Operationalizing early antiretroviral therapy in HIV-infected in-patients with opportunistic infections including tuberculosis.

Sunpath H, Edwin C, Chelin N, Nadesan S, Maharaj R, Moosa Y, Smeaton L, Court R, Knight S, Gwyther E, Murphy RA.

Int J Tuberc Lung Dis. 2012 Jul;16(7):917-23. doi: 10.5588/ijtld.11.0651.

PMID:
22687498
20.

Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.

Martín-Echevarria E, Rodríguez-Zapata M, Torralba M, Fernández JM, Moreno A, Casado JL, Dronda F, Pérez-Elías MJ, Navas E, Moreno S.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1347-52. doi: 10.5588/ijtld.10.0686.

PMID:
22283893

Supplemental Content

Support Center